A 38-year-old man from Mumbai undergoes total thyroidectomy for a 3.5 cm papillary thyroid carcinoma (PTC) with extrathyroidal extension and 2 positive cervical lymph nodes (T4aN1bM0, Stage IVA). Histology confirms classic PTC with no RAS mutation. Postoperative TSH is 0.8 mIU/L on levothyroxine 100 mcg daily. What is the most appropriate next step in management?

Explanation

## Management of Intermediate-to-High-Risk Papillary Thyroid Carcinoma **Key Point:** This patient has intermediate-to-high-risk PTC (extrathyroidal extension, nodal metastases, large size) and requires radioactive iodine (RAI) ablation after TSH stimulation to eliminate residual thyroid tissue and any iodine-avid metastases. ### Risk Stratification in PTC | Risk Category | Features | Management | |---|---|---| | **Low risk** | Intrathyroidal, <4 cm, no nodal/distant mets, no aggressive histology | Levothyroxine suppression; TSH monitoring | | **Intermediate risk** | Extrathyroidal extension, nodal mets, aggressive histology, or vascular invasion | **RAI ablation** + TSH suppression | | **High risk** | Distant metastases, gross extrathyroidal extension, or incomplete resection | **RAI ablation** + TSH suppression ± EBRT | **High-Yield:** This patient meets intermediate-to-high-risk criteria due to: - Extrathyroidal extension (T4a) - Cervical lymph node metastases (N1b) - Tumor size 3.5 cm ### Why RAI Ablation is the Next Step 1. **Eliminates residual thyroid tissue:** Allows accurate thyroglobulin monitoring for recurrence detection 2. **Treats iodine-avid metastases:** Cervical lymph nodes and any occult distant mets may take up radioiodine 3. **Improves disease-free survival:** Randomized trials show RAI reduces recurrence in intermediate/high-risk PTC 4. **Requires TSH stimulation:** TSH must be elevated (>30 mIU/L) to maximize iodine uptake; achieved by: - Levothyroxine withdrawal × 4–6 weeks, OR - Recombinant human TSH (rhTSH) injection × 2 days **Clinical Pearl:** The current postoperative TSH (0.8 mIU/L) is suppressed; TSH must be raised before RAI therapy to optimize ablation efficacy. rhTSH is preferred in elderly or cardiac patients to avoid hypothyroid symptoms. ### Post-RAI Management ```mermaid flowchart TD A[PTC with extrathyroidal extension + nodal mets]:::outcome --> B[Total thyroidectomy]:::action B --> C[Raise TSH to >30 mIU/L]:::action C --> D[131I ablation]:::action D --> E[Post-RAI scan]:::action E --> F{Residual uptake?}:::decision F -->|Yes| G[Repeat RAI or EBRT]:::action F -->|No| H[TSH suppression + Tg monitoring]:::action H --> I[Long-term follow-up]:::outcome ``` **Mnemonic:** **TRIG** = Thyroidectomy, Raise TSH, Radioiodine ablation, Iodine scan follow-up [cite:American Thyroid Association 2015 PTC Management Guidelines]